TM - Aspen Aerogels stock gains on foreseeing FY2022 revenue above prior outlook and consensus

Aspen Aerogels (NYSE:ASPN) has raised revenue outlook for FY2022 from $145M - $155M to $180M - $200M vs. consensus of $154.84M, driven by additional thermal barrier volumes order for 2022 from General Motors (GM) and Toyota (TM) also resulting in an updated outlook in thermal barrier revenues from $18M to a range of $52M to $62M. The company is also accelerating capital expenditures to execute its growth plans through 2025 to $250M and $300M vs. prior range of $250M and $275M for FY2022. Adjusted EBITDA loss is expected to range between $55M - $62M vs. previous loss range of $42M and -$46M driven by the increase in expected net loss. Diluted EPS for the year is expected to range between $2.20 and $2.40, as compared to the previous range of $1.88 and $1.99 and consensus of $1.91. Commenting on today's announcement, Donald R. Young, President and CEO, stated, "Our updated outlook for the

For further details see:

Aspen Aerogels stock gains on foreseeing FY2022 revenue above prior outlook and consensus